-
公开(公告)号:US07511058B2
公开(公告)日:2009-03-31
申请号:US11410336
申请日:2006-04-24
IPC分类号: A61K31/437 , C07D471/02
CPC分类号: C07D471/04 , C07D261/20
摘要: Disclosed are compounds of the Formula III and pharmaceutically acceptable salts and prodrugs thereof, wherein R1, R2, R7, R8, R9 R10, and W are as defined in the specification. Such compounds are MEK inhibitors and useful in the treatment of hyperproliferative diseases, such as cancer and inflammation, in mammals. Also disclosed are methods of using such compounds in the treatment of hyperproliferative diseases in mammals and pharmaceutical compositions containing such compounds.
摘要翻译: 公开了式III的化合物及其药学上可接受的盐和前药,其中R 1,R 2,R 7,R 8,R 9 R 10和W如说明书中所定义。 这些化合物是MEK抑制剂,可用于治疗哺乳动物中的过度增生性疾病,例如癌症和炎症。 还公开了使用这些化合物治疗哺乳动物中过度增殖性疾病的方法和含有这些化合物的药物组合物。
-
22.
公开(公告)号:US07400302B2
公开(公告)日:2008-07-15
申请号:US11343167
申请日:2006-01-30
申请人: James Blake Winter
发明人: James Blake Winter
摘要: An antenna for a foldable wireless device is provided. The foldable wireless device and antenna include a first housing and a second housing pivotally connected. A printed circuit board associated with the wireless device comprises a first PCB in the first housing and a second PCB in the second housing. The first and second PCB function as first and second radiating plates respectively. A gap, generally aligned with the pivotal connection separates the first and second PCBs. A short is provided that traverses the gap and connects the first and second PCBs. Radio frequency power is connected to the first and second PCB to supply radio frequency power.
摘要翻译: 提供了一种用于可折叠无线设备的天线。 可折叠无线装置和天线包括第一壳体和枢轴连接的第二壳体。 与无线装置相关联的印刷电路板包括第一壳体中的第一PCB和第二壳体中的第二PCB。 第一和第二PCB分别作为第一和第二辐射板。 通常与枢转连接对准的间隙分离第一和第二PCB。 提供穿过间隙并连接第一和第二PCB的短路。 射频电源连接到第一和第二PCB以提供射频功率。
-
公开(公告)号:USD551222S1
公开(公告)日:2007-09-18
申请号:US29237886
申请日:2005-09-08
-
公开(公告)号:US07271178B2
公开(公告)日:2007-09-18
申请号:US11410343
申请日:2006-04-24
申请人: Eli M. Wallace , James Blake
发明人: Eli M. Wallace , James Blake
IPC分类号: C07D471/04 , A61K31/437
CPC分类号: C07D471/04 , C07D261/20
摘要: Disclosed are compounds of the Formula V and pharmaceutically acceptable salts and prodrugs thereof, wherein R1, R2, R7, R8, R9, R10, R11 and W are as defined in the specification. Such compounds are MEK inhibitors and useful in the treatment of hyperproliferative diseases, such as cancer and inflammation, in mammals. Also disclosed are methods of using such compounds in the treatment of hyperproliferative diseases in mammals and pharmaceutical compositions containing such compounds.
摘要翻译: 公开了式V的化合物及其药学上可接受的盐和前药,其中R 1,R 2,R 7,R 4, 8,R 9,R 10,R 11和W如说明书中所定义。 这些化合物是MEK抑制剂,可用于治疗哺乳动物中的过度增生性疾病,例如癌症和炎症。 还公开了使用这些化合物治疗哺乳动物中过度增殖性疾病的方法和含有这些化合物的药物组合物。
-
公开(公告)号:US20070197537A1
公开(公告)日:2007-08-23
申请号:US11699830
申请日:2007-01-30
申请人: James Blake , Steven Boyd , Jason De Meese , John Gaudino , Allison Marlow , Jeongbeob Seo , Allen Thomas , Hongqi Tian
发明人: James Blake , Steven Boyd , Jason De Meese , John Gaudino , Allison Marlow , Jeongbeob Seo , Allen Thomas , Hongqi Tian
IPC分类号: A61K31/503 , A61K31/519 , A61K31/4743 , C07D498/02
CPC分类号: C07D495/04 , C07D519/00
摘要: Compounds of Formula I and pharmaceutically acceptable salts thereof, are useful for inhibiting receptor tyrosine kinases and for treating disorders mediated thereby. Methods of using compounds of Formula I and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.
摘要翻译: 式I化合物及其药学上可接受的盐可用于抑制受体酪氨酸激酶和用于治疗由此介导的病症。 公开了使用式I化合物及其药学上可接受的盐在体外,原位和体内诊断,预防或治疗哺乳动物细胞或相关病理状况中的这种病症的方法。
-
公开(公告)号:US07109932B2
公开(公告)日:2006-09-19
申请号:US10871432
申请日:2004-06-18
CPC分类号: G01R29/105
摘要: The present invention provides, an antenna test device to test antenna efficiency. The test device includes a cavity formed by at least one conductive sidewall. The cavity contains at least one tuning probe, at least one movable portion, or a combination thereof. The tuning probes and/or movable portion help inhibit the antenna under test from having faulty measurements due to anti resonance or coupling.
摘要翻译: 本发明提供一种用于测试天线效率的天线测试装置。 测试装置包括由至少一个导电侧壁形成的空腔。 空腔包含至少一个调谐探针,至少一个可移动部分或其组合。 调谐探针和/或可移动部分有助于阻止被测天线由于抗共振或耦合而产生故障测量。
-
公开(公告)号:US20060030610A1
公开(公告)日:2006-02-09
申请号:US11208442
申请日:2005-08-19
申请人: Kevin Koch , T. Hurley , Hong Yang , Joseph Lyssikatos , James Blake , Allison Marlow , Eli Wallace
发明人: Kevin Koch , T. Hurley , Hong Yang , Joseph Lyssikatos , James Blake , Allison Marlow , Eli Wallace
IPC分类号: A61K31/42 , C07D261/20
CPC分类号: C07D261/20 , A61K31/42 , C07D417/06 , C07D471/04
摘要: Disclosed are methods of treating inflammatory diseases and disorders, such as arthritis and inflammatory bowel disease, in mammals.
-
公开(公告)号:US20050284084A1
公开(公告)日:2005-12-29
申请号:US10861676
申请日:2004-06-04
申请人: James Blake
发明人: James Blake
CPC分类号: E04B1/26 , E04B2001/268 , E04B2001/2696
摘要: My invention, the Shear Wall Aspect Ratio Reducing Frame is a simple, economical, efficient, easy to install device that allows greater oppotunity and flexibility in the size and location of openings in the walls of wood frame constructed buildings particularly houses. The ARRF would replace the commercial, pre-fabricated systems now in use which are costly and inefficient labor-intensive shear wall devices. The ARRF achieves its goal by reducing the moment arm in the overturning equations that are used to determine the uplift forces in a shear wall. The ARRF reduces forces in walls rather than increase their bulk which is the strategic concept now in use throughout the design professions and the construction industry to solve the aspect ratio problem.
摘要翻译: 我的发明,剪切墙纵横比减速框架是一种简单,经济,高效,易于安装的设备,可以在木框架建筑物,特别是房屋的墙壁上的开口尺寸和位置上实现更大的对抗性和灵活性。 ARRF将取代现在使用的商业,预制的系统,这些系统是昂贵且无效的劳动密集型剪力墙装置。 ARRF通过减少用于确定剪力墙隆起力的倾覆方程中的力矩臂来实现其目标。 ARRF减少墙壁的力量,而不是增加其体积,这是现在在整个设计行业和建筑行业使用的战略概念来解决纵横比问题。
-
公开(公告)号:US20050256123A1
公开(公告)日:2005-11-17
申请号:US11132164
申请日:2005-05-18
申请人: Allison Marlow , Eli Wallace , Jeongbeob Seo , Joseph Lyssikatos , Hong Yang , James Blake
发明人: Allison Marlow , Eli Wallace , Jeongbeob Seo , Joseph Lyssikatos , Hong Yang , James Blake
IPC分类号: A61K31/4439 , A61K31/501 , A61K31/655 , C07D213/80 , C07D213/82 , C07D237/24 , C07D401/04 , C07D401/06 , C07D413/02 , C07D413/04 , C07D413/14 , C07D417/02 , C07D417/04 , C07D471/04 , C07D43/02
CPC分类号: C07D213/80 , A61K31/437 , A61K31/4412 , A61K31/4439 , A61K31/444 , A61K31/497 , A61K31/50 , A61K31/501 , A61K31/5025 , A61K31/5377 , A61K45/06 , C07D209/46 , C07D213/82 , C07D215/48 , C07D231/56 , C07D237/24 , C07D237/28 , C07D237/32 , C07D239/74 , C07D401/04 , C07D401/06 , C07D413/04 , C07D413/14 , C07D417/04 , C07D471/04 , A61K2300/00
摘要: Disclosed are compounds of the Formula I and pharmaceutically acceptable salts and prodrugs thereof, wherein R1, R2, R7, R8 and R9, W, X and Y are as defined in the specification. Such compounds are MEK inhibitors and useful in the treatment of hyperproliferative diseases, such as cancer and inflammation, in mammals, and inflammatory conditions. Also disclosed are methods of using such compounds in the treatment of hyperproliferative diseases in mammals and pharmaceutical compositions containing such compounds.
摘要翻译: 公开了式I化合物及其药学上可接受的盐和前药,其中R 1,R 2,R 7,R 4, 8和R 9,W,X和Y如说明书中所定义。 这些化合物是MEK抑制剂,可用于治疗哺乳动物和炎性病症中的过度增殖性疾病,例如癌症和炎症。 还公开了使用这些化合物治疗哺乳动物中过度增殖性疾病的方法和含有这些化合物的药物组合物。
-
公开(公告)号:US20050153942A1
公开(公告)日:2005-07-14
申请号:US10992479
申请日:2004-11-18
申请人: Eli Wallace , Jeongbeob Seo , Joseph Lyssikatos , Hong Yang , T. Hurley , Allison Marlow , James Blake
发明人: Eli Wallace , Jeongbeob Seo , Joseph Lyssikatos , Hong Yang , T. Hurley , Allison Marlow , James Blake
IPC分类号: A01N33/02 , A01N43/42 , A01N43/54 , A01N43/58 , A01N43/60 , A01N43/64 , A01N43/90 , A61K20060101 , A61K31/40 , A61K31/415 , A61K31/416 , A61K31/44 , A61K31/4439 , A61K31/4745 , A61K31/495 , A61K31/50 , A61K31/501 , A61K31/502 , A61K31/517 , A61K31/519 , A61K31/53 , A61K31/655 , C07D20060101 , C07D209/44 , C07D209/46 , C07D213/80 , C07D213/82 , C07D215/48 , C07D221/04 , C07D231/56 , C07D237/24 , C07D237/26 , C07D237/28 , C07D237/32 , C07D239/74 , C07D401/04 , C07D401/06 , C07D403/02 , C07D413/02 , C07D413/04 , C07D413/14 , C07D417/02 , C07D417/04 , C07D471/02 , C07D471/04 , C07D487/02 , C07D491/02 , C07D498/02
CPC分类号: C07D209/46 , C07D213/80 , C07D213/82 , C07D215/48 , C07D231/56 , C07D237/24 , C07D237/28 , C07D237/32 , C07D239/74 , C07D401/04 , C07D401/06 , C07D413/04 , C07D413/14 , C07D417/04 , C07D471/04
摘要: Disclosed are compounds of the Formula I and pharmaceutically acceptable salts and prodrugs thereof, wherein R1, R2, R7, R8 and R9, W, X, Y and Z are as defined in the specification. Such compounds are MEK inhibitors and are useful in the treatment of hyperproliferative diseases, such as cancer and inflammation, in mammals, and inflammatory conditions. Also disclosed are methods of using such compounds in the treatment of hyperproliferative diseases in mammals and pharmaceutical compositions containing such compounds.
摘要翻译: 公开了式I化合物及其药学上可接受的盐和前药,其中R 1,R 2,R 7,R 4, 8和R 9,W,X,Y和Z如说明书中所定义。 这些化合物是MEK抑制剂,并且可用于治疗哺乳动物和炎性病症中的过度增生性疾病,例如癌症和炎症。 还公开了使用这些化合物治疗哺乳动物中过度增殖性疾病的方法和含有这些化合物的药物组合物。
-
-
-
-
-
-
-
-
-